New Drug Approvals

Home | Pages | Archives

Considerations in the clinical development of biotech medicines

August 4, 2013 7:09 am


DR ANTHONY MELVIN CRASTO Ph.D's avatarDRUG REGULATORY AFFAIRS INTERNATIONAL

http://www.topra.org/sites/default/files/regrapart/1/4844/regrap-january2012-development-biotech-medicines.pdf

View original post

Share this:

Posted by DR ANTHONY MELVIN CRASTO Ph.D

Categories: Uncategorized

Tags:

One Response to “Considerations in the clinical development of biotech medicines”

  1. Reblogged this on MedCheminAustralia.

    Like

    By medchemnintabelle on August 5, 2013 at 5:52 am

Leave a Reply

Mobile Site | Full Site

Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.